PREZCOBIX

NDC 50090-1723 · A-S Medication Solutions

Generic nameDARUNAVIR ETHANOLATE and COBICISTAT

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)DARUNAVIR ETHANOLATE, COBICISTAT

Strength150; 800 mg/1; mg/1

Pharmacologic classBreast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC]

Marketing categoryNDA

Packages

50090-1723-0 — 30 TABLET, FILM COATED in 1 BOTTLE (50090-1723-0)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0003-3641 — atazanavir and cobicistat, 59676-562 — darunavir, 59676-563 — darunavir, 59676-564 — darunavir, 59676-565 — darunavir, 59676-566 — darunavir, 59676-575 — DARUNAVIR ETHANOLATE and COBICISTAT, 59676-577 — DARUNAVIR ETHANOLATE and COBICISTAT, 59676-578 — DARUNAVIR ETHANOLATE and COBICISTAT, 59676-800 — Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide, 61958-1201 — elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate, 61958-1401 — COBICISTAT, 61958-1901 — elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide, 68180-345 — DARUNAVIR, 68180-346 — DARUNAVIR

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.